Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression.
Igarashi T, Araki K, Yokobori T, Altan B, Yamanaka T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Handa T, Hosouchi Y, Nishiyama M, Oyama T, Shirabe K, Kuwano H.
Igarashi T, et al. Among authors: ishii n.
Oncotarget. 2017 Feb 14;8(7):12290-12300. doi: 10.18632/oncotarget.14703.
Oncotarget. 2017.
PMID: 28103577
Free PMC article.